Headaches occur in about 10% to 15% of users, most commonly during the first two weeks
What to expect with treatment These medications are administered as weekly injections and require regular monitoring, especially when starting treatment
Secondary endpoints included the rate of patients with a weight loss of 10%, monthly headache days (MHD), the rate of patients with a 30% and 50% reduction in MHD, visual outcome parameters, and adverse events (AEs)
& Goebell, H
There are currently 5-10 million people on a branded GLP-1 medication, but there is an estimated 50-60 million who are clinically eligible to receive Wegovy and have insurance coverage for it, and of those, millions could purchase it for a copay of less than $100/month
Quick Answer: Itching and swelling at the Zepbound injection site are usually localized immune responses